Scottsmyname, I will only clarify that IMO there will not be any phase 3 in Multiple system atrophy because MSA is an orphan disease and ATH434 has been granted an orphan status in the USA and EU. With orphan status, a drug can get to the market after positive results in phase 2. IMO, when Stamler has been talking about phase 3, he is talking about a phase 3 study for PD, even though he has not directly told so. It would be stupid to do a phase 3 study on MSA patients but very clever after the successful ape study to do a phase 3 study on PD patients. But of course, the side effects in phase 2 need to be close to the same level as in the placebo group.
- Forums
- ASX - By Stock
- ATH
- Ann: Notice Under Section 708A
Ann: Notice Under Section 708A, page-24
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 1248400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400000 | 0.006 |
43 | 36519865 | 0.005 |
38 | 52523682 | 0.004 |
44 | 45744982 | 0.003 |
15 | 32943014 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 1248400 | 1 |
0.006 | 19503993 | 16 |
0.007 | 20972790 | 19 |
0.008 | 15048071 | 18 |
0.009 | 9032078 | 9 |
Last trade - 09.33am 17/05/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
Day chart unavailable